In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
In the latest session, Clearside Biomedical Inc (NASDAQ: CLSD) closed at $0.35 up 3.00% from its previous closing price of $0.34. In other words, the price has increased by $3.00 from its previous closing price. On the day, 0.63 million shares were traded. CLSD stock price reached its highest trading level at $0.3535 during the session, while it also had its lowest trading level at $0.33.
Ratios:
For a deeper understanding of Clearside Biomedical Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.87 and its Current Ratio is at 3.87.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 24 ’25 when Thorp Clay bought 15,000 shares for $0.92 per share. The transaction valued at 13,800 led to the insider holds 176,141 shares of the business.
Chong Ngai Hang Victor bought 36,500 shares of CLSD for $36,500 on Nov 01 ’24. The Chief Medical Officer now owns 100,000 shares after completing the transaction at $1.00 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLSD now has a Market Capitalization of 27502160 and an Enterprise Value of 74361168. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.59. Its current Enterprise Value per Revenue stands at 17.85 whereas that against EBITDA is -3.453.
Stock Price History:
The Beta on a monthly basis for CLSD is 2.12, which has changed by -0.6391753 over the last 52 weeks, in comparison to a change of 0.20221436 over the same period for the S&P500. Over the past 52 weeks, CLSD has reached a high of $1.65, while it has fallen to a 52-week low of $0.29. The 50-Day Moving Average of the stock is -35.43%, while the 200-Day Moving Average is calculated to be -57.51%.
Shares Statistics:
For the past three months, CLSD has traded an average of 4.48M shares per day and 665360 over the past ten days. A total of 78.50M shares are outstanding, with a floating share count of 62.02M. Insiders hold about 21.00% of the company’s shares, while institutions hold 13.87% stake in the company. Shares short for CLSD as of 1755216000 were 1799248 with a Short Ratio of 0.40, compared to 1752537600 on 162565. Therefore, it implies a Short% of Shares Outstanding of 1799248 and a Short% of Float of 2.33.
Earnings Estimates
The firm’s stock currently is rated by 1.0 analysts. The consensus estimate for the next quarter is -$0.04, with high estimates of -$0.04 and low estimates of -$0.04.
Analysts are recommending an EPS of between -$0.18 and -$0.42 for the fiscal current year, implying an average EPS of -$0.3. EPS for the following year is -$0.32, with 6.0 analysts recommending between -$0.15 and -$0.48.
Revenue Estimates
A total of 3 analysts have provided revenue estimates for CLSD’s current fiscal year. The highest revenue estimate was $3.4M, while the lowest revenue estimate was $2.8M, resulting in an average revenue estimate of $3.19M. In the same quarter a year ago, actual revenue was $1.66M
